The Cardiometabolic Health Congress has announced Stanley Hazen, MD, PhD, Head of the Section for Preventive Cardiology and Rehabilitation of the Cleveland Clinic as its Keynote speaker for the 12th Annual CMHC, taking place October 4-7, 2017, at the Sheraton in Boston, MA. Specializing in preventive cardiovascular care, including the treatment of hyperlipidemia, diabetes, hypertension, and obesity, Dr. Hazen will discuss his groundbreaking work concerning gut microbes as a factor and therapeutic target in cardiometabolic diseases. Dr. Hazen has received numerous awards including election to membership in honorary societies in science and clinical arenas alike and also serves as reviewer and/or is on the editorial board for many scientific journals, including Circulation and the Journal of Lipid Research.
The ever-increasing obesity epidemic has placed that risk factor at the front of cardiovascular disease risk assessment and management. But specifically, how does body fat distribution impact cardiovascular risk? In the Keynote presentation, “Obesity Fat Distribution and Cardiovascular Risk,” Dr. Subodh Verma will evaluate the epidemiology and clinical course of visceral fat as it relates to cardiovascular event rates and explain the mechanistic basis of how visceral adiposity leads to cardiovascular disease. Additionally, Dr. Verma will shed light on the role of epicardial fat tissue as a source of inflammatory cytokines in cardiometabolic risk, critique the literature linking weight reduction to cardiometabolic risk reduction, and discuss the current guidelines for the management of cardiovascular risk in obesity.